Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients

Lancet

Volumn 351, Issue 9117, 1998, Pages 1701-1702

  Calne, Roy ^a   Friend, Peter ^b   Moffatt, Susan ^b   Bradley, Andrew ^b   Hale, Geoff ^b   Firth, John ^b   Bradley, John ^b   Smith, Ken ^b   Waldmann, Herman ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CYCLOSPORIN A;

ADULT; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOLOGICAL TOLERANCE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY FUNCTION; LYMPHOCYTOTOXICITY; MALE; PRIORITY JOURNAL;

EID: 0032490341     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)77739-4     Document Type: Article

References (5)

1. 1 Calne RY, Sells RA, Pena JR, et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969; 223: 472-76.
2. 2 Sriwatanawongsa V, Davies HFF, Calne RY. The essential roles of parenchymal tissues and passenger leukocytes in the tolerance induced by liver grafting in rats. Nat Med 1995; 1: 428-32.
3. 3 Calne RY, Watson CJE, Browns I, et al. Tolerance of porcine renal allografts induced by donor spleen cells and seven days' treatment with cyclosporin. Transplantation 1994; 57: 1433-35.
4. 4 Knechtle S, Vargo D, Fechner J, et al. FN18-CRM9 immunotoxin tolerance in primate renal allografts. Transplantation 1997; 63: 1-6.
5. 5 Hale G, Clark MR, Marcus R, et al. Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH 1H. Lancet 1988; 2: 1394-97.